Fecal microRNA signatures as non‐invasive diagnostic and prognostic markers of pediatric inflammatory bowel diseases
Journal of Pediatric Gastroenterology and Nutrition · 26.10.2026
DOI: 10.1002/jpn3.70620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 26.10.2026. Verfasst von Tereza Pinkasova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health, Czech Republic, Ministry of Health, Czech Republic: conceptual development of research organization.
Abstract (Originalsprache)
Objectives
The identification of novel noninvasive diagnostic and prognostic biomarkers for pediatric inflammatory bowel disease (PIBD), including pediatric Crohn's disease (pCD) and ulcerative colitis (pUC), is crucial for improving therapeutic outcomes. Given their involvement in PIBD pathogenesis, microRNAs (miRNAs) represent promising candidates. This study investigates their potential diagnostic value and clinical utility.
Methods
The study involved 81 treatment‐naive PIBD patients and 30 non‐IBD controls from whom stool samples were collected. Fecal microRNA analysis was performed using small RNA next‐generation sequencing. Differentially expressed miRNAs (DEMs) were identified in the exploratory phase (34 PIBD, 20 non‐IBD children). Logistic regression was used to establish diagnostic and prognostic miRNA expression signatures. The designed miRNA panels were validated using leave‐one‐out cross‐validation and on an independent cohort (47 PIBD, 10 non‐IBD children).
Results
A diagnostic signature of four fecal miRNAs (10392‐5p, miR‐1246, miR‐4695‐5p, and miR‐5006‐5p) distinguished pCD from non‐IBD with 79.55% accuracy. Three fecal miRNAs (miR‐1290, miR‐3960, and miR‐5006‐5p) differentiated pUC from non‐IBD with 78.26% accuracy. For treatment‐naïve PIBD patients, panels of five and six miRNAs predicted residual disease activity at 3 months with 100% accuracy for pUC patients and 86.28% accuracy for pCD patients. Additionally, distinct signatures of four and six miRNAs predicted relapse within 12 months with accuracies of 96.87% (pUC) and 88.01% (pCD), respectively.
Conclusion
We identified fecal miRNA expression profiles with strong diagnostic and prognostic value in PIBD. These results contribute to improved stratification of disease severity and risk, supporting the advancement of precision and personalized approaches in pediatric IBD management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- Department of Biology, Faculty of Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- Department of Pathology, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- Center for Precision Molecular Diagnostics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
ORCID-Profile: Tereza Pinkasova, Tereza Deissova, Matej Hrunka, Martina Ambrozova, Dagmar Al Tukmachi, Robin Jugas, Lenka Radova, Julia Bohosova, Tana Machackova, Leos Kren, Ondrej Slaby, Petr Jabandziev
Förderung
- Ministry of Health, Czech Republic
- Ministry of Health, Czech Republic: conceptual development of research organization
Zitieren
APA
Pinkasova, T., Deissova, T., Hrunka, M., Ambrozova, M., Al Tukmachi, D., Jugas, R., Radova, L., Bohosova, J., Machackova, T., Kren, L., Slaby, O., & Jabandziev, P. (2026). Fecal microRNA signatures as non‐invasive diagnostic and prognostic markers of pediatric inflammatory bowel diseases. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70620
Vancouver
Pinkasova T, Deissova T, Hrunka M, Ambrozova M, Al Tukmachi D, Jugas R, et al. Fecal microRNA signatures as non‐invasive diagnostic and prognostic markers of pediatric inflammatory bowel diseases. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70620
BibTeX
@article{Pinkasova2026,
author = {Pinkasova, Tereza and Deissova, Tereza and Hrunka, Matej and Ambrozova, Martina and Al Tukmachi, Dagmar and Jugas, Robin and Radova, Lenka and Bohosova, Julia and Machackova, Tana and Kren, Leos and Slaby, Ondrej and Jabandziev, Petr},
title = {Fecal microRNA signatures as non‐invasive diagnostic and prognostic markers of pediatric inflammatory bowel diseases},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70620}
}
EUVIMED